Pluri Inc. (PluriStem Life Systems, Inc.) 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by PluriStem Life Systems, Inc. (referred to as Pluri Inc. in metadata) on November 9, 2005. The registrant is incorporated in Nevada and maintains its principal executive offices in Haifa, Israel. The report discloses a corporate governance update regarding the Scientific Advisory Board.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel announcement and does not contain financial statements or performance data.
Material Changes
The material change reported is the appointment of Arnon Nagler, M.D., M.S.c., to the company's Scientific Advisory Board. Dr. Nagler is described as a world-renowned leader in human umbilical cord blood research, having established the first cord blood bank in Israel in 1994 and performed pioneering transplants and gene therapy procedures.
Guidance, Outlook, and Risks
The filing contains no financial guidance, forward-looking outlook, management commentary on financial performance, or discussion of specific risks and contingencies. The document serves solely to disclose the advisory board appointment under Regulation FD.
Key Facts for Investor Verification
- Arnon Nagler, M.D., M.S.c., joined the Scientific Advisory Board on November 9, 2005.
- Dr. Nagler's expertise includes stem cell separation, cord blood banking, and gene therapy transplantation.
- No financial data or operational metrics are included in this specific filing.
- The company's legal name at the time of filing was PluriStem Life Systems, Inc.